Company: HUM
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0000049071-25-000057
Chunk: 14

Company: HUMANA INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 2
Chunk 14
---
 and equity in net losses and diluted earnings per common share was as follows for the 2025 and 2024 quarter and period:

For the three months ended September 30,For the nine months ended September 30,2025202420252024(in millions)Consolidated income before income taxes and equity in net losses:Put/call valuation adjustments associated with our non consolidating minority interest investments$97 $(59)$460 $141 Impairment charges— — 32 — Settlement of certain litigation expenses15 — 15 — Loss on sale of business63 — 63 — Value creation initiatives267 55 320 151 Total$442 $(4)$890 $292 For the three months ended September 30,For the nine months ended September 30,2025202420252024Diluted earnings per common share:Put/call valuation adjustments associated with our non consolidating minority interest investments$0.80 $(0.49)$3.81 $1.17 Impairment charges— — 0.27 — Settlement of certain litigation expenses0.13 — 0.13 — Loss on sale of business0.52 — 0.52 — Value creation initiatives2.21 0.45 2.65 1.25 Cumulative net tax impact(1.72)0.01 (2.58)(0.56)Total$1.94 $(0.03)$4.80 $1.86 

36

Regulatory Environment

We are and will continue to be regularly subject to new laws and regulations, changes to existing laws and regulations, and judicial determinations that impact the interpretation and applicability of those laws and regulations. The Health Care Reform Law, the Families First Act, the CARES Act, and the Inflation Reduction Act, and related regulations, are examples of laws which have enacted significant reforms to various aspects of the U.S. health insurance industry, including, among others, mandated coverage requirements, mandated benefits and guarantee issuance associated with insurance products, rebates to policyholders based on minimum benefit ratios, adjustments to Medicare Advantage premiums, the establishment of federally facilitated or state-based exchanges coupled with programs designed to spread risk among insurers, and the introduction of plan designs based on set actuarial values, and changes to the Part D prescription drug benefit design.

It is reasonably possible that these laws and